<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">843966</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2022.843966</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Inspired by Nature: Towards Novel Anti-Infective Agents</article-title>
<alt-title alt-title-type="left-running-head">Ferreira et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Editorial: Nature-Derived Novel Anti-Infective Agents</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ferreira</surname>
<given-names>Ricardo J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/910106/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reis</surname>
<given-names>Mariana A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/899956/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silva</surname>
<given-names>Daniel</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/909936/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scapin</surname>
<given-names>Elisandra</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/909885/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dewanjee</surname>
<given-names>Saikat</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/363234/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carrasco</surname>
<given-names>Marta P.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/913375/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Red Glead Discovery AB</institution>, <addr-line>Lund</addr-line>, <country>Sweden</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Interdisciplinary Center for Marine and Environmental Research</institution>, <institution>University of Porto</institution>, <addr-line>Matosinhos</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Unilever</institution>, <addr-line>London</addr-line>, <country>United&#x20;Kingdom</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Federal University of Tocantins</institution>, <addr-line>Palmas</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Advanced Pharmacognosy Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University</institution>, <addr-line>Kolkata</addr-line>, <country>India</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Medicinal Chemistry, Faculty of Pharmacy, University of Lisbon</institution>, <addr-line>Lisbon</addr-line>, <country>Portugal</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/263224/overview">Alastair George Stewart</ext-link>, The University of Melbourne, Australia</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Ricardo J.&#x20;Ferreira, <email>ricardo.ferreira@redglead.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Translational Pharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>01</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>843966</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>12</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>01</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Ferreira, Reis, Silva, Scapin, Dewanjee and Carrasco.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Ferreira, Reis, Silva, Scapin, Dewanjee and Carrasco</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Pharmacol." xlink:href="https://www.frontiersin.org/researchtopic/13239" ext-link-type="uri">Editorial on the Research Topic <article-title>Inspired by Nature: Towards Novel Anti-Infective Agents</article-title>
</related-article>
<kwd-group>
<kwd>antibiotics</kwd>
<kwd>antivirals agents</kwd>
<kwd>drug development</kwd>
<kwd>eutectic liquids</kwd>
<kwd>natural products</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Since the dawn of mankind natural sources have been explored due their valuable medicinal properties. Even in modern times several compounds are still being identified in the natural source(s) from which anti-microbial activity was originally isolated. However, the world of natural products is still the largest unexplored chemical space when compared with the largest of the known chemical databases. Although remaining one of the best sources of chemical inspiration for the development of new drugs, only around a quarter million natural products are available within public databases and no more that ten percent can be readily obtainable from commercial vendors for experimental testing. The identification of such molecular scaffolds, either derived from plants, microorganisms or marine products, followed by isolation of active molecules and further chemical modification, allows researchers to further improve their pharmacological properties. Having strong roots in traditional medicine, in which plants and plant extracts only known to the medicine caregivers are used to treat all sorts of diseases, the identification of each compound responsible for that given activity is usually the first step in increasing the pool of chemical templates. This is why many compounds were first isolated from natural sources and used to develop drugs targeting specific diseases, from which salicylic acid, morphine and quinine are classical examples. However, due to the intricate complexity of some molecules, hemi-synthetic derivatives as etoposide and teniposide, paclitaxel or vinblastine/vincristine remains as the most feasible approach for obtaining more potent compounds in selected instances.</p>
<p>The main challenge within this topic was to use nature as an inspiration for new compounds that can pave the way for future pharmacological innovations. In this perspective, boron-containing DNA-binding ionic liquids as antimicrobial agents (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2020.01328/full">Rosa et&#x20;al.</ext-link>) or inspired by natural product nitrogen-containing 5-membered heterocyclic moieties (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2020.591570/full">Camargo et&#x20;al.</ext-link>) are two very interesting approaches in the development of new antibiotics. The identification of sugar-type compounds as antiviral agents is also remarkable (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2020.608707/full">Zhou et&#x20;al.</ext-link>), taking into account that generally sugar moieties are often ignored in drug development. Furthermore, novel techniques such as Molecular Dynamics, largely ignored in the natural products, are slowly increasing in importance as useful tools for the comprehension of more dynamic systems as nature-inspired eutectic solvents (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2021.626735/full">Monteiro et&#x20;al.</ext-link>).</p>
<p>Taken together these papers present a glimpse on the opportunities that nature continues to provide, when properly addressed. Therefore, further inspiration can be obtained by harnessing the enormous potential delivered by nature throughout its natural selection and evolution.</p>
</body>
<back>
<sec id="s1">
<title>Author Contributions</title>
<p>All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.</p>
</sec>
<sec sec-type="COI-statement" id="s2">
<title>Conflict of Interest</title>
<p>Author RF was employed by the company Red Glead Discovery AB. Author DS was employed by the company Unilever.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s3">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>